Welcome to our dedicated page for Axcelis Technologies news (Ticker: ACLS), a resource for investors and traders seeking the latest updates and insights on Axcelis Technologies stock.
Axcelis Technologies Inc. (Nasdaq: ACLS) is a world-leading provider of equipment and services to the semiconductor manufacturing industry. For over 35 years, Axcelis has been a trusted partner for chipmakers globally, delivering cutting-edge solutions and expertise in the critical process of ion implantation. This process is essential for the fabrication of semiconductor chips used in everyday electronics such as smartphones, laptops, cameras, and more.
The company's suite of products includes advanced ion implantation systems, which form transistors that power electronic devices. Axcelis' Purion™ platform is renowned for its flexibility and advanced technology, catering to diverse needs from high current to high energy implants. The Purion Power Series™, particularly, addresses the growing demand in power device applications, including silicon carbide (SiC) technology, crucial for automotive, industrial, and energy applications.
Axcelis also offers comprehensive aftermarket services, including spare parts, equipment upgrades, maintenance, and customer training, ensuring maximum operational efficiency and longevity of its products. The company’s advanced technology center in Beverly, Mass., serves as a hub for innovation, collaborating with industry experts and customers to develop next-generation applications.
Financially robust, Axcelis continues to achieve record performance. In 2023, the company reported a 23% year-over-year growth, with revenues surpassing $1.1 billion. The strong market position is further evidenced by a $1.2 billion backlog at the year's end. Axcelis' strategic focus on the Asia Pacific region, which contributes significantly to its revenue, underscores its global outreach and market adaptability.
Recent achievements highlight Axcelis' leadership and innovation. The company showcased its latest technologies at SEMICON Korea 2024 and announced multiple shipments of its Purion Power Series™ to leading chipmakers worldwide. Axcelis also strengthened its board with new directors, bringing in valuable industry expertise.
As the semiconductor industry evolves, Axcelis remains committed to driving innovation and supporting its customers with state-of-the-art ion implantation solutions, ensuring a bright and technologically advanced future.
Axcelis Technologies, Inc. (Nasdaq: ACLS) will release its financial results for Q1 2023 on May 3, 2023, at 4:00 p.m. ET, followed by a conference call on May 4, 2023, at 8:30 a.m. ET. Interested parties can access the call via an audio webcast on Axcelis' Investors page. The company, headquartered in Beverly, Massachusetts, specializes in high-productivity solutions for the semiconductor industry, focusing on ion implantation systems and complete life cycle support. For more information, visit www.axcelis.com.
Axcelis Technologies (Nasdaq: ACLS) announced the significant milestone of shipping its 500th Purion™ ion implanter system to a major semiconductor manufacturer in North America. This achievement underscores Axcelis' market leadership in providing ion implantation solutions for the semiconductor industry. According to President and CEO Mary Puma, this shipment validates the company’s strong customer partnerships and expanding manufacturing capabilities. The growing installed base of Purion systems is expected to bolster Axcelis' aftermarket business. The Purion platform is recognized for its advanced technology, particularly in image sensor and power device manufacturing.
Axcelis Technologies (Nasdaq: ACLS) has appointed Russell J. Low, Ph.D., as President and CEO effective May 11, 2023. He will succeed Mary G. Puma, who will become Executive Chairperson and remain a Senior Advisor. Dr. Low, previously Executive VP of Global Customer Operations and Engineering, played a key role in developing the Purion ion implant product line. Puma, who has led Axcelis for 22 years, emphasized the timing for this transition as ideal for future growth. The board expressed confidence in Dr. Low's leadership, highlighting his technical expertise and commitment to innovation, promising continued market leadership and value delivery.
Axcelis Technologies (NASDAQ: ACLS) announced on March 12, 2023, that the recent collapse of Silicon Valley Bank (SVB) is expected to have an immaterial impact on its operations. The company has an unused line of credit with SVB and maintains banking relationships with multiple US and foreign banks. As of December 31, 2022, Axcelis had $185.6 million in cash and cash equivalents, with $246.6 million in short-term investments primarily in U.S. Government securities. The company's liquidity will remain unaffected, and it has instructed clients to remit payments to non-SVB accounts.
Axcelis Technologies, Inc. (NASDAQ: ACLS), a semiconductor equipment supplier, announced on March 12, 2023, that the recent collapse of Silicon Valley Bank (SVB) will have an immaterial impact on its operations. The company highlighted its robust banking relationships with multiple U.S. and foreign banks, ensuring no liquidity issues. As of December 31, 2022, Axcelis held $185.6 million in cash and cash equivalents, alongside $246.6 million in short-term investments in U.S. Government and Agency securities. The company is taking steps to move deposits and ensure customer payments are unaffected.
Axcelis Technologies (Nasdaq: ACLS), based in Beverly, Mass., has announced its participation in two upcoming investor conferences. The first is the Susquehanna Financial Group Twelfth Annual Technology Conference, scheduled for March 2-3, 2023, at the Lotte New York Palace Hotel. Management will hold one-on-one meetings with investors on March 2. The second event is the Loop Capital Markets 2023 Investor Conference, taking place virtually on March 13 and in-person on March 14, 2023, also at the Lotte New York Palace Hotel, with one-on-one meetings on the latter date. Axcelis has over 40 years of experience providing ion implantation solutions for the semiconductor industry.